RT Journal Article SR Electronic T1 Twitter Interaction to Analyze Covid-19 Impact in Ghana, Africa from March to July JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.25.20182048 DO 10.1101/2020.08.25.20182048 A1 Josimar E. Chire Saire A1 Kobby Panford-Quainoo YR 2020 UL http://medrxiv.org/content/early/2020/08/31/2020.08.25.20182048.abstract AB Present pandemic generated by Coronavirus Covid-19 has stopped the world, from Tourism, Business, Education and more. Actually, there are reported cases in every continent from America to Europe, from Europe to Australia. Africa is one continent in process of development with a variety of languages, limitations/problems and of course, abundance of culture. The aim of this paper is to analyze the impact in one country located in the middle-west, named Ghana. The data source for the analysis is Twitter(Social Network) and the analysis is using a Text Mining approach. Besides, a composition of graphics are presented considering Google search, daily reported cases. The study is exploratory to know what topics are most frequent in Great Accra Region. The conclusions are: Twitter is useful to get data for the analysis, and the interest of user from Ghana was high at the beginning but it was decreasing from April until July, probably the people is tired or adapting themselves to the actual situation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementNot applicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be required through emails of the authors.